Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
CNS
Study Phase
Phase 3
Study Completion Date
August 2016
NCT01372774Uploaded 09-14-2022
Access via NCI by Request
PDS UID: nci-data-494
A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared With Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease
Provider Information
Provider Data DescriptionDataset NCT01372774-D1-Dataset.csv (baseline) is one of 5 datasets associated with PubMed ID 28687377. This dataset contains information that will allow you to reproduce the baseline characteristics table and time to event analyses.
SponsorAlliance for Clinical Trials in Oncology
Data ProviderNational Cancer Institute
Clinical Trials.gov Information
Brief SummaryRATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Radiation therapy uses high-energy x rays to kill tumor cells. It is not yet known whether stereotactic radiosurgery is more effective than whole-brain radiation therapy in treating patients with brain metastases that have been removed by surgery. PURPOSE: This randomized phase III trial studies how well stereotactic radiosurgery works compared to whole-brain radiation therapy in treating patients with brain metastases that have been removed by surgery.
ConditionsCognitive/Functional Effects
Metastatic Cancer
Neurotoxicity
Radiation Toxicity
Unspecified Adult Solid Tumor, Protocol Specific
Intervention TypeRadiation: stereotactic radiosurgery
Radiation: whole-brain radiation therapy
Drug(s)N/A
Total Enrolled194
RandomizationRandomized
Blinding MethodNone (Open Label)
Arms InterventionArm I - WBRT - Active Comparator
Arm II - SRS - Experimental
Secondary IDNCCTG-N107C
PubMed (PMID)36264568
28687377
Collaborator(s)National Cancer Institute (NCI)
Region(s)United States
Age Range18 Years and older (Adult, Older Adult)
Files: NCT01372774-D1
Data DictionaryNCT01372774-D1-Data-Dictionary_1.pdf
DATANCT01372774-D1-Dataset_1.csv
OTHERREADME.pdf
Files: NCT01372774-D2
Data DictionaryNCT01372774-D2-Data-Dictionary_1.pdf
DATANCT01372774-D2-Dataset_1.csv
OTHERREADME.pdf
Files: NCT01372774-D3
Data DictionaryNCT01372774-D3-Data-Dictionary_1.pdf
DATANCT01372774-D3-Dataset_1.csv
OTHERREADME.pdf
Files: NCT01372774-D4
Data DictionaryNCT01372774-D4-Data-Dictionary_1.pdf
DATANCT01372774-D4-Dataset_1.csv
OTHERREADME.pdf
Files: NCT01372774-D5
Data DictionaryNCT01372774-D5-Data-Dictionary_1.pdf
DATANCT01372774-D5-Dataset_1.csv
OTHERREADME.pdf
© 2024 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use